AlloSure is a test that detects possible kidney transplant rejection, which has been the subject of several lawsuits between Natera and CDNA related to is a good overview of the ongoing legal disputes between CDNA and Natera.

Source: https://seekingalpha.com/article/4660076-caredx-turmoil-risks-appear-priced-in?source=feed_all_articles

AlloSure is a test that detects possible kidney transplant rejection, which has been the subject of several lawsuits between Natera and CDNA related to is a good overview of the ongoing legal disputes between CDNA and Natera.

Source: https://seekingalpha.com/article/4660076-caredx-turmoil-risks-appear-priced-in?source=feed_all_articles

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CDNA.

Source: https://www.etfdailynews.com/2023/02/26/54966-shares-in-caredx-inc-nasdaqcdna-acquired-by-exoduspoint-capital-management-lp/